Trevi Therapeutics, Inc.

The current price of TRVI is 2.65 USD — it has decreased by 7.02% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Trevi Therapeutics, Inc. stocks are traded under the ticker TRVI.

Trevi Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

TRVI stock is 11.67% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is Trevi Therapeutics, Inc. there?

TRVI earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.09 USD resulting in a 12.73% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Trevi Therapeutics, Inc. earnings.

Yes, you can track Trevi Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

TRVI stock has fallen by 0.75% compared to the previous week, the month change is a 26.39% fall, over the last year Trevi Therapeutics, Inc. has showed a 9.25% decrease.

Today Trevi Therapeutics, Inc. has the market capitalization of ‪196.54 M‬, it has increased by 10.32% over the last week.

No, TRVI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, TRVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Trevi Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

TRVI reached its all-time high on Jun 3, 2019 with the price of 10.62 USD, and its all-time low was 0.46 USD and was reached on Feb 22, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 25.00 employees. See our rating of the largest employees — is Trevi Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Trevi Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Trevi Therapeutics, Inc. stock shows the buy signal. See more of Trevi Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Trevi Therapeutics, Inc. future price: according to them, TRVI price has a max estimate of 9.00 USD and a min estimate of 6.00 USD. Read a more detailed Trevi Therapeutics, Inc. forecast: see what analysts think of Trevi Therapeutics, Inc. and suggest that you do with its stocks.